Diarrhea was associated with anti-ATA (p=0.001) and anti-PM-Scl75 (p=0.005), abdominal pain with anti-RP 155 (p=0.023), GERD with anti-fibrillarin (p=0.011) and bloating with anti-Th/To (p=0.011). Here, FBL is linked to gastroesophageal reflux disease.